Axa’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-356,400
| Closed | -$816K | – | 1121 |
|
|
2023
Q2 | $816K | Hold |
356,400
| – | – | ﹤0.01% | 871 |
|
|
2023
Q1 | $866K | Buy |
356,400
+335,500
| +1,605% | +$815K | ﹤0.01% | 889 |
|
|
2022
Q4 | $39.9K | Sell |
20,900
-91,268
| -81% | -$174K | ﹤0.01% | 1118 |
|
|
2022
Q3 | $269K | Buy |
112,168
+91,268
| +437% | +$219K | ﹤0.01% | 1061 |
|
|
2022
Q2 | $38.9K | Hold |
20,900
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q1 | $43.7K | Sell |
20,900
-54,300
| -72% | -$113K | ﹤0.01% | 1177 |
|
|
2021
Q4 | $296K | Buy |
+75,200
| New | +$296K | ﹤0.01% | 1090 |
|
|
2021
Q3 | – | Sell |
-285,500
| Closed | -$1.31M | – | 1282 |
|
|
2021
Q2 | $1.31M | Sell |
285,500
-116,800
| -29% | -$536K | ﹤0.01% | 958 |
|
|
2021
Q1 | $2.36M | Buy |
402,300
+340,100
| +547% | +$2M | 0.01% | 823 |
|
|
2020
Q4 | $213K | Buy |
+62,200
| New | +$213K | ﹤0.01% | 1166 |
|
|
2020
Q2 | – | Sell |
-19,300
| Closed | -$38K | – | 1272 |
|
|
2020
Q1 | $38K | Sell |
19,300
-115,402
| -86% | -$227K | ﹤0.01% | 1159 |
|
|
2019
Q4 | $559K | Buy |
134,702
+50,702
| +60% | +$210K | ﹤0.01% | 980 |
|
|
2019
Q3 | $253K | Sell |
84,000
-44,600
| -35% | -$134K | ﹤0.01% | 1217 |
|
|
2019
Q2 | $809K | Buy |
128,600
+72,000
| +127% | +$453K | ﹤0.01% | 1008 |
|
|
2019
Q1 | $315K | Buy |
+56,600
| New | +$315K | ﹤0.01% | 1186 |
|
|
2014
Q3 | – | Sell |
-64,368
| Closed | -$725K | – | 1462 |
|
|
2014
Q2 | $725K | Sell |
64,368
-2,589
| -4% | -$29.2K | ﹤0.01% | 1000 |
|
|
2014
Q1 | $811K | Buy |
66,957
+3,487
| +5% | +$42.2K | ﹤0.01% | 971 |
|
|
2013
Q4 | $800K | Buy |
63,470
+3,157
| +5% | +$39.8K | ﹤0.01% | 969 |
|
|
2013
Q3 | $1M | Buy |
60,313
+12,220
| +25% | +$203K | ﹤0.01% | 871 |
|
|
2013
Q2 | $731K | Buy |
+48,093
| New | +$731K | ﹤0.01% | 890 |
|